Verition Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Sell |
11,505
-5,054
| -31% | -$109K | ﹤0.01% | 2555 |
|
|
2025
Q1 | $275K | Sell |
16,559
-66,063
| -80% | -$1.1M | ﹤0.01% | 2261 |
|
|
2024
Q4 | $1.52M | Buy |
+82,622
| New | +$1.52M | 0.01% | 1309 |
|
|
2024
Q3 | – | Sell |
-18,829
| Closed | -$306K | – | 2439 |
|
|
2024
Q2 | $306K | Buy |
+18,829
| New | +$306K | ﹤0.01% | 1709 |
|
|
2023
Q3 | – | Sell |
-15,427
| Closed | -$369K | – | 1945 |
|
|
2023
Q2 | $369K | Buy |
+15,427
| New | +$369K | ﹤0.01% | 1205 |
|
|
2022
Q3 | – | Sell |
-11,793
| Closed | -$166K | – | 2412 |
|
|
2022
Q2 | $166K | Buy |
+11,793
| New | +$166K | ﹤0.01% | 1908 |
|
|
2021
Q4 | – | Sell |
-10,036
| Closed | -$167K | – | 1809 |
|
|
2021
Q3 | $167K | Buy |
+10,036
| New | +$167K | ﹤0.01% | 1385 |
|
|
2020
Q4 | – | Sell |
-5,996
| Closed | -$247K | – | 948 |
|
|
2020
Q3 | $247K | Sell |
5,996
-31,121
| -84% | -$1.28M | ﹤0.01% | 777 |
|
|
2020
Q2 | $1.8M | Buy |
+37,117
| New | +$1.8M | 0.06% | 205 |
|
|
2020
Q1 | – | Sell |
-40,605
| Closed | -$1.74M | – | 487 |
|
|
2019
Q4 | $1.74M | Buy |
40,605
+26,405
| +186% | +$1.13M | 0.03% | 227 |
|
|
2019
Q3 | $511K | Sell |
14,200
-47,174
| -77% | -$1.7M | 0.01% | 511 |
|
|
2019
Q2 | $1.64M | Buy |
+61,374
| New | +$1.64M | 0.05% | 229 |
|
|
2018
Q3 | – | Sell |
-10,695
| Closed | -$163K | – | 1139 |
|
|
2018
Q2 | $163K | Buy |
+10,695
| New | +$163K | 0.01% | 934 |
|
|
2017
Q4 | – | Sell |
-9,217
| Closed | -$347K | – | 795 |
|
|
2017
Q3 | $347K | Buy |
+9,217
| New | +$347K | 0.03% | 722 |
|
|
2017
Q2 | – | Sell |
-19,639
| Closed | -$675K | – | 825 |
|
|
2017
Q1 | $675K | Buy |
+19,639
| New | +$675K | 0.06% | 365 |
|